# An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

> **NCT01351987** · — · UNKNOWN · sponsor: **Taipei Medical University WanFang Hospital** · enrollment: 855 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01351987
- **Lead sponsor:** Taipei Medical University WanFang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** —
- **Final completion:** 2013-12
- **Target enrollment:** 855 (ESTIMATED)
- **Last updated:** 2011-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01351987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01351987, "An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01351987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*